Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Pharmacol Ther. 2019 Dec 31;107(5):1200–1208. doi: 10.1002/cpt.1714

Figure 2.

Figure 2.

GM and 95% CI for plasma concentration-time profiles for TFV (top) and FTC (bottom) concentrations for the T +PRO (open blue squares) and C IPERGAY (closed black circles) treatments.